In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
The combination of Alpelisib and fulvestrant specifically targeted patients with···【more】
Release date:2024-08-23Recommended:444
Koselugois a multifunctional targeted therapy drug, which can be used as a small···【more】
Release date:2024-08-23Recommended:436
Koselugo is a targeted therapy that targets specific cancers by inhibiting the a···【more】
Release date:2024-08-23Recommended:451
Koselugo is a targeted therapy drug for the treatment of low-grade serous ovaria···【more】
Release date:2024-08-23Recommended:467
Koselugois an anti-cancer drug targeting MEK protein, which can successfully blo···【more】
Release date:2024-08-23Recommended:439
Koselugo is an MEK protein-targeted anticancer agent that can effectively cut th···【more】
Release date:2024-08-23Recommended:452
Koselugo is an anti-cancer drug targeting MEK protein, which inhibits tumor cell···【more】
Release date:2024-08-23Recommended:530
By targeting and inhibiting the activity of MEK protein, Koselugo effectively cu···【more】
Release date:2024-08-23Recommended:448
Koselugoinhibits tumor cell proliferation by inhibiting MEK protein activity, bl···【more】
Release date:2024-08-23Recommended:402
Koselugo is a targeted therapy drug primarily used to treat a specific subtype o···【more】
Release date:2024-08-23Recommended:440
Alpelisib is a drug for the treatment of HR/HER2- breast cancer, especially for ···【more】
Release date:2024-08-22Recommended:450
Alpelisib for the treatment of PIK3CA-mutated HR/HER2- advanced breast cancer in···【more】
Release date:2024-08-22Recommended:459